Category: Scientific and technical

DesertSci is pleased to continue supporting our major pharmaceutical and biotech clients in their global research efforts into finding therapeutic treatments for Covid-19.

New tools for the identification, classification, annotation and exploration of biologics entities have been added to the Proasis suite.

At DesertSci, our aim is to create innovative, new technologies for drug designers that lead directly to new small-molecule chemical candidates based on structure-based design, fragment scanning and unique chemical fragment entities.

DesertSci is developing new AI models based on DeepLearning for better predicting properties such as ligand affinity and binding site flexibility.

The reporting functionality of Proasis4 has been greatly extended with the addition of the new option of Clustering Binding Site Atoms.